NEWS BY INDUSTRY

Radius-122214.jpg Radius Health Inc.'s (RDUS) phase III trial of its product candidate Abaloparatide-SC has demonstrated success in reducing fractures in women with postmenopausal osteoporosis. We alerted our premium subscribers to RDUS on October 20, 2014 when it was trading around $18. Did you buy this stock?
Biotechnology-122214.jpg Orexigen Therapeutics Inc.'s (OREX) Mysimba has received positive opinion from European Medicines Agency's Committee for Medicinal Products For Human Use, recommending approval of the drug in the European Union as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults.
NorthKorea-122014.jpg Confirming widespread speculation, the Federal Bureau of Investigation on Friday formally accused North Korea of the recent cyber-attack against Sony Pictures Entertainment. The FBI said it began an investigation shortly after attack and has concluded that the North Korean government is responsible.
Follow Us RTTNews on Twitter RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube
Add to Google